Author: ["David T Woodley","Douglas R Keene","Tom Atha","Yi Huang","Kathi Lipman","Wei Li","Mei Chen"]
CITE.CC academic search helps you expand the influence of your papers.
Abstract
Dystrophic epidermolysis bullosa (DEB) is a family of inherited mechano-bullous disorders that are caused by mutations in the type VII collagen gene and for which ex vivo gene therapy has been considered. To develop a simpler approach for treating DEB, we evaluated the feasibility of protein-based therapy by intradermally injecting human recombinant type VII collagen into mouse skin and a DEB human skin equivalent transplanted onto mice. The injected collagen localized to the basement membrane zone of both types of tissues, was organized into human anchoring fibril structures and reversed the features of DEB disease in the DEB skin equivalent.Cite this article
Woodley, D., Keene, D., Atha, T. et al. Injection of recombinant human type VII collagen restores collagen function in dystrophic epidermolysis bullosa. Nat Med 10, 693–695 (2004). https://doi.org/10.1038/nm1063 